Harvard University Clinical Trials
Sponsors / Harvard University
ClinicalTrials.gov lists 111 trials for which Harvard University is named as lead sponsor. Of these, 3 are recruiting, 8 are active without new recruitment, and 82 have completed. The registry records 5 terminated or withdrawn trials for Harvard University. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Planned participant enrollment across these trials sums to 369,616. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
111
Total Trials
3
Recruiting
8
Other Active
82
Completed
5
Terminated / Withdrawn
369,616
Total Enrollment
Termination reasons: Recruitment60% · Funding20% · Other20%
Recent Terminations
- Glaucoma"Low recruitment"
- Distress, Emotional"Slow recruitment and enrollment. Unable to reach target N."
- Distress, Emotional"Slow recruitment and enrollment. Unable to meet target N."
- Diabetes"Harvard University dining workers went on strike, we hope to relaunch in Fall 2017."
- NCT04233944 Stopped Nov 2016Anemia"Funding constraints"
Active Trials (8 total)
- NCT03029429
- NCT04725721
- NCT03706014
- Anxiety NANCT05449002
- NCT02710370
- Depression NANCT05456607
- Tinnitus NANCT05710172
- NCT03412162
- NCT03881605
- NCT05230199
- NCT04033757